Document is current
Any future updates will be listed below
-
Authors
Florit, Anita https://orcid.org/0000-0003-0469-6335
de Koster, Elizabeth J. https://orcid.org/0000-0001-8111-1172
Sassano, Serena
Alic, Lejla https://orcid.org/0000-0001-6487-6958
Pisano, Giusi https://orcid.org/0000-0001-9627-5065
van Velden, Floris H. P. https://orcid.org/0000-0003-2859-2119
Annunziata, Salvatore https://orcid.org/0000-0003-3241-1501
Primac, Irina https://orcid.org/0000-0001-7989-5027
Ruggiero, Maria Rosaria https://orcid.org/0000-0003-2374-6692
Müller, Cristina https://orcid.org/0000-0001-9357-9688
Sala, Evis https://orcid.org/0000-0002-5518-9360
Fendler, Wolfgang P. https://orcid.org/0000-0002-5106-3584
Scambia, Giovanni https://orcid.org/0000-0002-9503-9041
de Geus-Oei, Lioe-Fee https://orcid.org/0000-0003-1817-2743
Fagotti, Anna https://orcid.org/0000-0001-5579-335X
Rufini, Vittoria https://orcid.org/0000-0002-1045-0633
Collarino, Angela https://orcid.org/0000-0001-6162-9767
-
Funding
Funding for this research was provided by:
Innovative Health Initiative (101172788)
Università Cattolica del Sacro Cuore
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 8 April 2025
First Online: 25 April 2025
Declarations
:
: Not applicable.
: W.P.F. reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speaker), Perceptive (consultant, image review), Bayer (consultant, speaker, research funding), Novartis (speaker, consultant), Telix (speaker), GE Healthcare (speaker, consultant), Eczacıbaşı Monrol (speaker), Abx (speaker), Amgen (speaker), Urotrials (speaker), Lilly (consultant) outside of the submitted work. The rest of the authors report that they have no conflict of interest.
